Use of mycophenolate mofetil in autoimmune and renal diseasesAPPEL, Gerald B; RADHAKRISHNAN, Jai; GINZLER, Ellen M et al.Transplantation. 2005, Vol 80, Num 2, pp S265-S271, issn 0041-1337, SUPArticle

Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS studyISENBERG, David; APPEL, Gerald B; CONTRERAS, Gabriel et al.Rheumatology (Oxford. Print). 2010, Vol 49, Num 1, pp 128-140, issn 1462-0324, 13 p.Article

Effects of prasterone on bone mineral density in women with systemic lupus erythematosus receiving chronic glucocorticoid therapyMEASE, Philip J; GINZLER, Ellen M; GLUCK, Oscar S et al.Journal of rheumatology. 2005, Vol 32, Num 4, pp 616-621, issn 0315-162X, 6 p.Article

The classification of glomerulonephritis in systemic lupus erythematosus revisitedWEENING, Jan J; D'AGATI, Vivette D; FOGO, Agnes B et al.Kidney international. 2004, Vol 65, Num 2, pp 521-530, issn 0085-2538, 10 p.Article

Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritisRADHAKRISHNAN, Jai; MOUTZOURIS, Dimitrios-Anestis; GINZLER, Ellen M et al.Kidney international. 2010, Vol 77, Num 2, pp 152-160, issn 0085-2538, 9 p.Article

Effects of Prasterone on Bone Mineral Density in Women with Active Systemic Lupus Erythematosus Receiving Chronic Glucocorticoid TherapySANCHEZ-GUERRERO, Jorge; FRAGOSO-LOYO, Hilda E; DEODHAR, Atul A et al.Journal of rheumatology. 2008, Vol 35, Num 8, pp 1567-1575, issn 0315-162X, 9 p.Article

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritisGINZLER, Ellen M; DOOLEY, Mary Anne; APPEL, Gerald B et al.The New England journal of medicine. 2005, Vol 353, Num 21, pp 2219-2228, issn 0028-4793, 10 p.Article

Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: A double-blind, randomized, placebo-controlled trialPETRI, Michelle A; LAHITA, Robert G; VAN VOLLENHOVEN, Ronald F et al.Arthritis and rheumatism. 2002, Vol 46, Num 7, pp 1820-1829, issn 0004-3591Article

Long-Term Safety Profile of Belimumab Plus Standard Therapy in Patients With Systemic Lupus ErythematosusMERRILL, Joan T; GINZLER, Ellen M; PINEDA, Lilia et al.Arthritis and rheumatism. 2012, Vol 64, Num 10, pp 3364-3373, issn 0004-3591, 10 p.Article

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus NephritisAPPEL, Gerald B; CONTRERAS, Gabriel; WOFSY, David et al.Journal of the American Society of Nephrology. 2009, Vol 20, Num 5, pp 1103-1112, issn 1046-6673, 10 p.Article

Systemic Lupus International Collaborating Clinics Renal Activity/Response Exercise : Comparison of Agreement in Rating Renal ResponsePETRI, Michelle; KASITANON, Nuntana; WALLACE, Daniel J et al.Arthritis and rheumatism. 2008, Vol 58, Num 6, pp 1789-1795, issn 0004-3591, 7 p.Article

Familiality and co-occurrence of clinical features of systemic lupus erythematosusTSAR, Betty P; GROSSMAN, Jennifer M; KALUNIAN, Kenneth C et al.Arthritis and rheumatism. 2002, Vol 46, Num 10, pp 2678-2685, issn 0004-3591Article